Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors - review of assay methodologies and perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors - review of assay methodologies and perspectives

Published:2014-11-26 Issue:6 Volume:29 Page:803-834
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomed. Chromatogr.

Author:

Sharma Kuldeep¹,Suresh P. S.¹,Mullangi Ramesh¹,Srinivas N. R.²³

Affiliation:

1. Jubilant Biosys, Second Stage; Industrial Suburb; Yeswanthpur Bangalore- 560 022 India

2. Semler Research; VI Phase, J. P. Nagar Bangalore- 560 078 India

3. CEO, Bioneeds India Private Lmited, Tumkur Road; Nelamangala Taluk, Bangalore Rural District; India

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference49 articles.

1. Validation of a liquid chromatography assay for the quantification of the Raf kinase inhibitor BAY 43-9006 in small volumes of mouse serum;Afify;Journal of Chromatography B,2004

2. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS;Andriamanana;Journal of Chromatography B,2013

3. Quantitation of SU1 1248, an oral multi-target tyrosine kinase inhibitor, and its metabolite in monkey tissues by liquid chromatograph with tandem mass spectrometry following semi-automated liquid-liquid extraction;Baratte;Journal of Chromatography A,2004

4. Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice;Blanchet;Journal of Pharmaceutical and Biomedical Analysis,2009a

5. Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasma;Blanchet;Clinica Chimica Acta,2009b

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of some novel quinazoline-thioacetamide derivatives as anticancer agents, apoptotic inducers, radio-sensitizers, and VEGFR inhibitors;Journal of Molecular Structure;2024-12

2. Utility of sulfachloropyridazine in the synthesis of novel anticancer agents as antiangiogenic and apoptotic inducers;Bioorganic Chemistry;2024-07

3. Novel NO-TZDs and trimethoxychalcone-based DHPMs: design, synthesis, and biological evaluation as potential VEGFR-2 inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-06-21

4. Discovery of novel pyrazole based Urea/Thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 Inhibitors, with anti-cancer and anti-inflammatory activities;Bioorganic Chemistry;2024-06

5. Novel guanidine derivatives targeting leukemia as selective Src/Abl dual inhibitors: Design, synthesis and anti-proliferative activity;Bioorganic Chemistry;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3